The DOI matches its Crossref record.
The Human Homologs of the raf ( mil ) Oncogene Are Located on Human Chromosomes 3 and 4
Abstract
Two human genes that are homologous to both the murine transforming gene (oncogene) v- raf and the chicken transforming gene v-mil have been mapped by means of human-rodent somatic cell hybrids to human chromosomes previously devoid of known oncogenes. One gene, c- raf -2, which appears to be a processed pseudogene, is located on chromosome 4. The other gene, c- raf -1, which appears to be the active gene, is located on chromosome 3 and has been regionally mapped by chromosomal in situ hybridization to 3p25. This assignment correlates with specific chromosomal abnormalities associated with certain human malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Holderfield, M., Deuker, M. M., McCormick, F., & McMahon, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3760 · Cited by 833
Vemurafenib: the first drug approved for BRAF-mutant cancer
Bollag, G., Tsai, J., Zhang, J., Zhang, C., Ibrahim, P., Nolop, K., & Hirth, P. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3847 · Cited by 822
Regulation of RAF protein kinases in ERK signalling
Lavoie, H., & Therrien, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3979 · Cited by 702
Constitutive Fragile Sites and Cancer
Yunis, J. J., & Soreng, A. L. (1984) · Science · doi:10.1126/science.6239375 · Cited by 680
Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
Seizinger, B. R., Rouleau, G. A., Ozelius, L. J., Lane, A. H., Farmer, G. E., Lamiell, J. M., Haines, J., Yuen, J. W. M., Collins, D., Majoor-Krakauer, D., et al. (1988) · Nature · doi:10.1038/332268a0 · Cited by 662
Self-citationEvolution of tumours and the impact of molecular oncology
Klein, G., & Klein, E. (1985) · Nature · doi:10.1038/315190a0 · Cited by 661
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Degirmenci, U., Wang, M., & Hu, J. (2020) · Cells · doi:10.3390/cells9010198 · Cited by 534
The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
Yuan, J., Dong, X., Yap, J., & Hu, J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00949-4 · Cited by 493
Anchored reference loci for comparative genome mapping in mammals
O'Brien, S. J., Womack, J. E., Lyons, L. A., Moore, K. J., Jenkins, N. A., & Copeland, N. G. (1993) · Nature Genetics · doi:10.1038/ng0293-103 · Cited by 429
Self-citationOncogene Amplification in Tumor Cells
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60201-8 · Cited by 346
Jones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Ichimura, K., & Collins, V. P. (2009) · Oncogene · doi:10.1038/onc.2009.73 · Cited by 321
Raf kinases: Function, regulation and role in human cancer
Leicht, D. T., Balan, V., Kaplun, A., Singh-Gupta, V., Kaplun, L., Dobson, M., & Tzivion, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.001 · Cited by 317
Activated Oncogenes in B6C3F1 Mouse Liver Tumors: Implications for Risk Assessment
Reynolds, S. H., Stowers, S. J., Patterson, R. M., Maronpot, R. R., Aaronson, S. A., & Anderson, M. W. (1987) · Science · doi:10.1126/science.3629242 · Cited by 275
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas
Dürst, M., Croce, C. M., Gissmann, L., Schwarz, E., & Huebner, K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.4.1070 · Cited by 232
Metadata
- Authors
- Bonner, T., O'Brien, S. J., Nash, W. G., Rapp, U. R., Morton, C. C., & Leder, P.
- Venue
- Science
- Published
- 1984-01-06
- Volume
- 223
- Issue
- 4631
- Pages
- 71-74
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2073190753
- Cited by
- 181
- References
- 0
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.